On November 28, 2017 SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, reported that the Company will participate in the following upcoming investor conferences (Press release, Scynexis, NOV 28, 2017, View Source [SID1234522275]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Know more, wherever you are:
Latest on SCYNEXIS’s Cancer Pipeline, book your free 1stOncology demo here.
The Global Mizuho Investor Conference (MIC) NY at the Lotte New York Palace Hotel on Monday, December 4, 2017.
The Guggenheim Securities 5th Annual Boston Healthcare Conference at the InterContinental Boston on Wednesday, December 13, 2017.